Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$20.9M Sell
63,729
-1,700
-3% -$539K 4.51% 9
2025
Q3
$18.5M Sell
65,429
-507
-0.8% -$147K 4.02% 16
2025
Q2
$18.4M Sell
65,936
-3,678
-5% -$1.04M 4.17% 15
2025
Q1
$21.7M Buy
69,614
+2,813
+4% +$831K 4.9% 2
2024
Q4
$17.4M Buy
66,801
+352
+0.5% +$104K 3.75% 18
2024
Q3
$21.4M Sell
66,449
-490
-0.7% -$160K 4.63% 4
2024
Q2
$20.9M Sell
66,939
-1,739
-3% -$511K 4.82% 5
2024
Q1
$19.5M Sell
68,678
-6,752
-9% -$1.98M 4.55% 7
2023
Q4
$21.7M Buy
75,430
+4,740
+7% +$1.29M 4.78% 6
2023
Q3
$19M Buy
70,690
+25
+0% +$6.24K 4.76% 4
2023
Q2
$15.7M Buy
70,665
+6,901
+11% +$1.6M 4.03% 16
2023
Q1
$15.4M Sell
63,764
-860
-1% -$211K 4.28% 14
2022
Q4
$17M Sell
64,624
-8,688
-12% -$2.33M 4.37% 8
2022
Q3
$16.5M Sell
73,312
-635
-0.9% -$154K 4.56% 5
2022
Q2
$18M Sell
73,947
-716
-1% -$175K 5.07% 3
2022
Q1
$18.1M Buy
74,663
+2,111
+3% +$485K 4.01% 12
2021
Q4
$16.3M Buy
72,552
+17,280
+31% +$3.65M 3.61% 19
2021
Q3
$11.8M Buy
55,272
+1,995
+4% +$459K 3.01% 23
2021
Q2
$13M Buy
53,277
+1,007
+2% +$248K 3.18% 23
2021
Q1
$13M Buy
52,270
+1,095
+2% +$261K 3.32% 20
2020
Q4
$11.8M Buy
51,175
+1,120
+2% +$258K 3.16% 23
2020
Q3
$12.7M Buy
50,055
+855
+2% +$212K 4.08% 9
2020
Q2
$11.6M Sell
49,200
-145
-0.3% -$33.1K 4.18% 8
2020
Q1
$10M Buy
+49,345
New +$10.8M 4.25% 11

Other funds holding AMGN

Vantage Wealth's AMGN Position: Q4 2025 in Review

Vantage Wealth reduced its Amgen (AMGN) stake by 2.6% in Q4 2025, selling an estimated $539K and leaving 63,729 shares worth $20.9M. The position accounts for 4.51% of the portfolio, ranked #9.

Vantage Wealth first reported a position in AMGN in Q1 2020 and has held it in 24 quarters since. The position peaked at $21.7M in Q4 2023. 3,086 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Vantage Wealth held 63,729 shares of Amgen worth $20.9M as of Q4 2025.
  • Vantage Wealth sold 1,700 Amgen shares in Q4 2025, an estimated $539K.
  • Amgen made up 4.51% of Vantage Wealth's portfolio in Q4 2025, its #9 holding.
  • Vantage Wealth first reported a position in Amgen in Q1 2020 and has held it in 24 quarters since.
  • Vantage Wealth's Amgen position peaked at $21.7M in Q4 2023.
  • 3,086 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Vantage Wealth's 13F filing for Q4 2025, filed 14 Jan 2026.